Abstract:Background:The overlap between asthma and chronic obstructive pulmonary disease (COPD) is an important clinical phenomenon. However, the prevalence of asthma–COPD overlap syndrome (ACOS) is not known.Aims:To investigate the prevalence of ACOS among asthmatic patients with a smoking history, and evaluate the factors predicting ACOS in this patient group.Methods:We investigated 190 primary care asthma patients with no previous diagnosis of COPD, but who were either current or ex-smokers, with a smoking history o… Show more
“…Age over 60 and higher burden of smoking history (over 20 pack-years) were associated with being part of the overlap group in this study. (16) A similar study of 256 Korean patients with asthma (defined by bronchodilator reversibility or positive methacholine challenge) found that 38% had incompletely reversible airflow obstruction on two separate occasions at least 3 months apart. This group was noted to be older, higher proportion male, and have more current and former smokers than the group with asthma alone.…”
Section: Proposed Pathways To Acos Presented As 4 Phenotypesmentioning
confidence: 98%
“…(8) The estimated prevalence of the syndrome appears to vary based upon the population studied and the definitions utilized to describe the syndrome, but has been estimated between 13% and 38% of the population with obstructive lung disease. (9–21) Most estimates of prevalence of ACOS among a population of individuals with asthma appears to be slightly higher, with estimates ranging 27.1%–38%(13, 16, 18), whereas estimates of ACOS within a population of individuals with COPD appear to be slightly lower, ranging mostly from 13%–28.6%. (9–11, 14, 17, 19–21) Other than the differences in population characteristics which may account for the variation in prevalence estimates, the definitions utilized to identify individuals with ACOS also differ greatly.…”
Section: Prevalence and Epidemiology Of Asthma/copd Overlap Syndromementioning
Synopsis
The debate about whether asthma and chronic obstructive pulmonary disease (COPD) are distinct clinical syndromes is not new, but there has been a heightened interest in recent years in understanding the group of individuals with obstructive lung disease who appear to have elements of both asthma and COPD. These patients are of interest because of recent studies which have demonstrated increased risk for respiratory events and exacerbations in this group. We describe the clinical characteristics of this subtype of disease and suggest 4 working definitions of individuals who would fall into the asthma/COPD overlap category. These definitions shed light on the clinical and inflammatory characteristics surrounding the group with overlap syndrome in order to better understand the biologic mechanisms for their worsened outcomes. Understanding the mechanisms underlying these subtypes will hopefully lead into a better understanding of therapeutic strategies that can target specific pathobiologic pathways.
“…Age over 60 and higher burden of smoking history (over 20 pack-years) were associated with being part of the overlap group in this study. (16) A similar study of 256 Korean patients with asthma (defined by bronchodilator reversibility or positive methacholine challenge) found that 38% had incompletely reversible airflow obstruction on two separate occasions at least 3 months apart. This group was noted to be older, higher proportion male, and have more current and former smokers than the group with asthma alone.…”
Section: Proposed Pathways To Acos Presented As 4 Phenotypesmentioning
confidence: 98%
“…(8) The estimated prevalence of the syndrome appears to vary based upon the population studied and the definitions utilized to describe the syndrome, but has been estimated between 13% and 38% of the population with obstructive lung disease. (9–21) Most estimates of prevalence of ACOS among a population of individuals with asthma appears to be slightly higher, with estimates ranging 27.1%–38%(13, 16, 18), whereas estimates of ACOS within a population of individuals with COPD appear to be slightly lower, ranging mostly from 13%–28.6%. (9–11, 14, 17, 19–21) Other than the differences in population characteristics which may account for the variation in prevalence estimates, the definitions utilized to identify individuals with ACOS also differ greatly.…”
Section: Prevalence and Epidemiology Of Asthma/copd Overlap Syndromementioning
Synopsis
The debate about whether asthma and chronic obstructive pulmonary disease (COPD) are distinct clinical syndromes is not new, but there has been a heightened interest in recent years in understanding the group of individuals with obstructive lung disease who appear to have elements of both asthma and COPD. These patients are of interest because of recent studies which have demonstrated increased risk for respiratory events and exacerbations in this group. We describe the clinical characteristics of this subtype of disease and suggest 4 working definitions of individuals who would fall into the asthma/COPD overlap category. These definitions shed light on the clinical and inflammatory characteristics surrounding the group with overlap syndrome in order to better understand the biologic mechanisms for their worsened outcomes. Understanding the mechanisms underlying these subtypes will hopefully lead into a better understanding of therapeutic strategies that can target specific pathobiologic pathways.
“…In a cross-sectional study in primary care investigating the prevalence of ACOS among asthmatic patients with a smoking history of at least 10 pack-years almost 25% were considered as having ACOS. In this study age over 60 years and a smoking history of more than 20 pack-years were the best predictors of ACOS [16].…”
Section: The Overlap Between Asthma and Chronic Obstructive Pulmonarymentioning
Smoking asthma represents a common challenge to the clinician both in terms of diagnosis and management. These aspects have not been thoroughly evaluated and deserve further investigation.
“…A study by Kiljander et al revealed ACOS prevalence as 27.4% in asthma patients who have a history of smoking. Smoking 20 pack years and age over 60 years were best predictors of ACOS in the study population and these risk factors together increase ACOS risk 6 fold (p: 0.001) [16]. The reason suggested to explain high ACOS prevalence is that asthma and airway hyperresponsiveness to be among the COPD risk factors.…”
Section: Definition and Diagnosis Of Acosmentioning
Asthma and chronic obstructive pulmonary disease (COPD) are the two most prevalent obstructive diseases of the lung. Although asthma and COPD differ in many ways some properties of each disease co-exist in some patients, particularly in patients with advanced age which recently brought up the term; Asthma-COPD Overlap Syndrome (ACOS). In addition to the fact that clinical trials deliberately exclude the patients in this group, the diagnostic criteria of ACOS are not well established. Both of these factors contribute to paucity of evidence based clinical information about ACOS. In this article my aim is to provide brief information about the history, description, clinical properties and treatment of this disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.